Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
VolitionRx Limited Schedules Full Year 2018 Earnings Conference Call and Business Update 2019-03-07 21:30
VolitionRx Limited to Expand its Nu.Q(TM) Trials to Veterinary Diagnostics 2018-10-04 21:00
VolitionRx Limited Releases Video Featuring Interviews with its Scientific Advisory Board 2018-09-26 21:00
VolitionRx Limited to Attend Multiple Conferences in September 2018-09-05 20:30
Preliminary Data from Study Demonstrates 94% Accuracy in Detecting Aggressive Prostate Cancer 2018-08-13 20:30
VolitionRx Announces $9 Million Private Placement 2018-08-08 18:00
VolitionRx Limited Schedules Second Quarter 2018 Earnings Conference Call and Business Update 2018-08-07 20:35
VolitionRx's First Research Use Only Product Is "On-The-Shelf" Today 2018-08-01 19:00
Volition Secures Additional $700,000 Non-Dilutive Funding from the Walloon Region 2018-07-02 20:30
VolitionRx Limited to Attend the Bank of America Merrill Lynch 2018 Health Care Conference from May 15-17, 2018 2018-05-14 21:00
VolitionRx Limited Announces First Quarter 2018 Financial Results and Business Update 2018-05-11 04:05
VolitionRx Signs a Global Sales and Distribution Agreement with Active Motif for its new RUO kits 2018-05-09 21:00
VolitionRx Limited Schedules First Quarter 2018 Earnings Conference Call and Business Update 2018-05-04 20:00
VolitionRx Announces Closing of $8.4 Million Public Offering of Common Stock 2018-03-14 04:05
VolitionRx Announces Pricing of $8.4 Million Public Offering of Common Stock 2018-03-09 22:10
VolitionRx Announces Proposed Underwritten Public Offering of Common Stock 2018-03-09 05:01
VolitionRx Appoints Harvard Professor, Dr. Lee-Jen Wei to Its Scientific Advisory Board 2018-03-07 21:30
VolitionRx Limited Schedules Full Year 2017 Earnings Conference Call and Business Update 2018-03-01 05:05
VolitionRx Limited Announces Interim Results from 680-Subject Clinical Trial in Colorectal Cancer 2018-02-27 05:05
VolitionRX Announces the Successful Conclusion of the Logistics and Pathway Design Study Conducted in Denmark. 2018-02-05 21:30
1 3 4 5 6 7